Cadila Healthcare Ltd :

793.65 6.15 [0.78%]

ISIN: INE010B01019 | NSE: CADILAHC | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 532321 | Comments

Price Information
• Open	783.00
• High	797.90
• Low	778.25
• Previous Close	787.50
• Shares Traded	2632
• 52 Wk High Price	964.00
• 52 Wk High Date	12-09-2012
• 52 Wk Low Price	705.05
• 52 Wk Low Date	04-06-2012
• Face Value	5.00

Fundamentals
• Market Capital (Rs.cr)	16103.80
• EPS (Rs.)(TTM)	19.72
• P/E Ratio(TTM)	39.91
• Book Value (Rs.)	124.50
• Price to Book Value	6.32
• Equity (Rs.cr.)	102.37
• Traded Value (Rs.lac)	67.07

Corporate Actions
Ex-Date	Purpose (Rs.)
2011-07-07	125% Dividend (6.25)
2012-07-26	150% Dividend (7.5)

Index Names
• BSE-200
• BSE-500
• BSE HC

Related Companies
Stock Name	Price

CIPLA	408.25
JBCHEPHARM	82.65
JAYANTVITAMINS	3.00	-
MERIND	200.00	-
PIRHEALTH	557.75
RANBAXY	390.30
UNICHEMLAB	170.35
ALEMBICLTD	19.20
LYKALABS	9.57
TTKHEALTH	633.60

Share Tips for Cadila Healthcare Ltd

'BUY' Cadila Healthcare Ltd with a tar (12:09PM, Jul 18 '12)

BUY Cadila Healthcare Ltd.Short Term T (12:15PM, Jan 23 '12)

Buy Cadila Healthcare Ltd above 888.40 (12:19PM, Jul 20 '11)

Buy Cadila Healthcare Ltd below 897.3 (03:56PM, Jun 28 '11)

Buy Cadila Healthcare Ltd below 897.35 (02:40PM, Jun 28 '11)

Mutual funds holding in Cadila Healthcare Ltd

ICICI Prudential Dynamic Plan - Growth

Kotak Opportunities Fund - Growth

Baroda Pioneer Growth Fund - Growth

ICICI Prudential Discovery Fund - Growth

Reliance Vision - Growth

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Dec, 2012	Dec, 2012	Mar, 2012
• Sales (Rs.cr)	647.75	3222.68	3150.80
• Net Profit (Rs.cr)	33.96	403.69	657.70
• Net Profit Var (%)	-75.00	-34.00	8.00
• EPS (Rs)	-	19.72	31.30
• P/E Ratio	-	39.91	25.10
• Operating Profit Margin	-	17.40	-
• CPS (Rs.)	-	-	36.60
• P/C Ratio	-	-	21.50
• Div%	-	-	150.00

Announcements
08-09-2012	Cadila healthcare received final approval for Tramadol Hydrochloride and Acetaminophen tablets
20-07-2012	Cadila Healthcare inks pact with Somaxon for Silenor
23-04-2011	Cadila Healthcare to announce financial results
07-07-2011	Cadila Healthcare to announce Q1 results
18-10-2011	Cadila Healthcare to announce Q2 results
06-01-2011	Cadila Healthcare to announce Q3 results
21-12-2011	Zydus acquires 100% stake in Mumbai-based Biochem
28-07-2011	Zydus Cadila acquires Bremer Pharma GmbH from ICICI Venture
26-03-2011	Zydus Cadila gets final approval for the Propranolol hydrochloride Mylan, Watson Labs, Sandoz, IPCA
27-02-2013	Zydus Cadila gets tentative approval for Doxepin Hcl tablets
01-10-2012	Zydus receives approval for Irbesartan Tablets
03-05-2013	Zydus Wellness - Board to consider Dividend

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

21-05-2013 2989 4518 66.16 2355631 3588.28
20-05-2013 3482 5354 65.04 2812411 4399.88
17-05-2013 2260 5586 40.46 1849697 4642.00
13-05-2013 3297 10320 31.95 2653755 8325.57
11-05-2013 68 87 78.16 53924 68.94

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Cadila Healthcare Ltd

Hot Searches • seinvest • jswener • smallcap • geometri • dhanban • alembic • sbin • ibn18 • lanco • wwil

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
21-05-2013	2989	4518	66.16	2355631	3588.28
20-05-2013	3482	5354	65.04	2812411	4399.88
17-05-2013	2260	5586	40.46	1849697	4642.00
13-05-2013	3297	10320	31.95	2653755	8325.57
11-05-2013	68	87	78.16	53924	68.94